Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder

NCT00707980 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00707980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2010
Enrollment
836 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder